Cargando…
Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target “mtFabH” of Mycobacterium tuberculosis
Mycolic acids are the key constituents of mycobacterial cell wall, which protect the bacteria from antibiotic susceptibility, helping to subvert and escape from the host immune system. Thus, the enzymes involved in regulating and biosynthesis of mycolic acids can be explored as potential drug target...
Autores principales: | Kumar, Niranjan, Srivastava, Rakesh, Mongre, Raj Kumar, Mishra, Chandra Bhushan, Kumar, Amit, Khatoon, Rosy, Banerjee, Atanu, Ashraf-Uz-Zaman, Md, Singh, Harpreet, Lynn, Andrew M., Lee, Myeong-Sok, Prakash, Amresh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121832/ https://www.ncbi.nlm.nih.gov/pubmed/35602011 http://dx.doi.org/10.3389/fmicb.2022.818714 |
Ejemplares similares
-
Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure?
por: Mongre, Raj Kumar, et al.
Publicado: (2021) -
Identification of 2-Aminothiazole-4-Carboxylate Derivatives Active against Mycobacterium tuberculosis H(37)R(v) and the β-Ketoacyl-ACP Synthase mtFabH
por: Al-Balas, Qosay, et al.
Publicado: (2009) -
Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004): in vitro and in vivo studies
por: Mishra, Chandra Bhushan, et al.
Publicado: (2021) -
Novel Carbazole-Piperazine Hybrid Small Molecule Induces Apoptosis by Targeting BCL-2 and Inhibits Tumor Progression in Lung Adenocarcinoma In Vitro and Xenograft Mice Model
por: Mongre, Raj Kumar, et al.
Publicado: (2019) -
Prognostic and Clinicopathological Significance of SERTAD1 in Various Types of Cancer Risk: A Systematic Review and Retrospective Analysis
por: Mongre, Raj Kumar, et al.
Publicado: (2019)